No Picture
News

NextCure hires Celgene vet as CMO; José Vega leaves Merck to become Moderna’s chief safety officer

NextCure has found its new CMO after the previous executive resigned last August.
Han Myint, a biopharma and academia veteran of more than 20 years, joined the company Thursday after serving as CMO at NexImmune for a little over a year. Myint had overs… […]

No Picture
HealthCoronavirusinfectious diseasepublic health

In LA, ambulances circle for hours and ICUs are full. Is this what Covid-19 has in store for the rest of the country?

Do the overwhelmed hospitals in Los Angeles offer a glimpse of what other regions may soon face as case counts rise steeply and a seemingly more infectious strain takes hold? […]

No Picture
News

City of Hope Scientists Have Developed a Precision Medicine Tool That Predicts If Chemotherapy Will Produce Debilitating Side Effects in Older Adults

DUARTE, Calif.–(BUSINESS WIRE)–First-of-its-kind risk assessment tool developed by City of Hope helps oncologists make personalized treatment recommendations. […]

No Picture
News

Amgen tops cost watchdog’s price gougers list based on ‘unfounded’ increases for Enbrel without meaningful data

In a top 10 ranking of the most egregious price gougers from 2019, Amgen’s Enbrel topped US cost watchdog ICER’s naughty list with “unfounded” markups that added as much as $403 million to the nation’s drug spend during that time. Price increases for s… […]

No Picture
News

A much-hyped CV drug failed, repeatedly. Now, investors are betting nearly $200M on one last PhIII bid

Just under a decade ago, Eli Lilly announced early results for a new drug that lowered bad cholesterol and raised good cholesterol. It was a “holy grail” result, as JAMA put it in a press release, offering a path for a pill that could curb cardiovascul… […]

No Picture
News

Global WholeHealth Partners, Corp (OTC: GWHP) Announces New Purchase Agreement From RyZac Health as Order Size Increases Over 3 Times

San Clemente, CA, Jan. 13, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Global WholeHealth Partners Corp, a multinational supplier of over 70+ with 56 products FDA approved and several approved for export only including Dengue, Ebola, Zika, Malaria a… […]

No Picture
Nasdaq:ARQTUS03969K1088

Arcutis Initiates Pivotal Phase 3 Clinical Trials Evaluating Topical Roflumilast Cream (ARQ-151) as a Potential Treatment for Atopic Dermatitis

WESTLAKE VILLAGE, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a medical dermatology company developing innovative treatments for patients with immune-mediated dermatological diseases and conditions, today a… […]

No Picture
Featured NewsUncategorized

An international team, including UCLA scientists, discover the dire wolf was a distinct species, different from the gray wolf

The post An international team, including UCLA scientists, discover the dire wolf was a distinct species, different from the gray wolf appeared first on Life Sciences.
[…]